js4399金沙线路

PARTNERING We are looking forward to establishing solid collaboration with partners around the world.

Partnering with us

We believe that partnerships are the key to sustainable growth and success, and prepare to share the following advantages with partner:


Highest reputation & awards in China, strong R&D for API and FDF, patent regulation, cost effectiveness, high compliance standards, state-of-art facilities, most advanced machinery and equipment, and vertical integration.


Research collaboration
API supply, especially for product with high entry barrier
Out-licensing
Technology transfer
Co-development for API or FDF
CMO production

Featured case studies

  • Johnson & Johnson
    and CTTQ Pharmaceutical Group:
    Entered into a license agreement for development and commercialization of one innovative drug for curative treatment of Hepatitis B.
  • Bio Line
    Rx and CTTQ Pharmaceutical Group:
    Entered into an agreement for co-development and commercialization of an oral drug (BL-8030) for curative treatment of Hepatitis C.
8455新葡萄娱乐-www.8455.com|最新官网 金沙js6038登录|金沙js6038手机版|金沙6038官方网站 永利集团手机娱乐场网址-www.304.com|全网独家